Determination of catecholamines in plasma and urine

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 27, Issue 5, 2013, Pages 713-723

  Grouzmann, Eric ^a   Lamine, Faiza ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b LA RABTA HOSPITAL   (Tunisia)

Author keywords

catecholamines; dopamine; epinephrine; metanephrines; neuroblastoma; norepinephrine; pheochromocytoma

Indexed keywords

AMITRIPTYLINE; AMLODIPINE; AMPHETAMINE DERIVATIVE; ATENOLOL; CAFFEINE; CARBIDOPA; CATECHOLAMINE; COCAINE; DOXAZOSIN; EPHEDRINE; IMIPRAMINE; LABETALOL; LEVODOPA; METADRENALIN; METOPROLOL; NICOTINE; NIFEDIPINE; PHENOXYBENZAMINE; PRAZOSIN; PROPRANOLOL; PSEUDOEPHEDRINE; SELEGILINE;

ALCOHOL CONSUMPTION; BLOOD ANALYSIS; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE METABOLISM; CATECHOLAMINE SYNTHESIS; CATECHOLAMINE URINE LEVEL; CONCENTRATION (PARAMETERS); DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIET; DIFFERENTIAL DIAGNOSIS; DRUG ABUSE; FALSE NEGATIVE RESULT; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NEUROBLASTOMA; PANIC; PHEOCHROMOCYTOMA; REVIEW; SENSITIVITY AND SPECIFICITY; SLEEP DISORDERED BREATHING; SMOKING; URINALYSIS;

CATECHOLAMINES; DOPAMINE; EPINEPHRINE; METANEPHRINES; NEUROBLASTOMA; NOREPINEPHRINE; PHEOCHROMOCYTOMA;

ADRENAL GLAND NEOPLASMS; CATECHOLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FALSE POSITIVE REACTIONS; HUMANS; METANEPHRINE; NEUROBLASTOMA; PHEOCHROMOCYTOMA; TANDEM MASS SPECTROMETRY;

EID: 84885321163     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2013.06.004     Document Type: Review

References (87)

1. G. Eisenhofer, I.J. Kopin, and D.S. Goldstein Catecholamine metabolism: a contemporary view with implications for physiology and medicine Pharmacological Review 56 2004 331 349
2. M.J. Brown, and D.J. Alison Renal conversion of plasma DOPA to urine dopamine British Journal of Clinical Pharmacology 12 1981 251 253
3. U.S. von Euler, and U. Hamberg Colorimetric estimation of noradrenalin in the presence of adrenalin Science 110 1949 561
4. A.H. Anton, and D.F. Sayre A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines The Journal of Pharmacology and Experimental Therapeutics 138 1962 360 375
5. M. Da Prada, and G. Zürcher Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range Life Sciences 19 1976 1161 1174
6. T.G. Rosano, T.A. Swift, and L.W. Hayes Advances in catecholamine and metabolite measurements for diagnosis of pheochromocytoma Clinical Chemistry 37 1991 1854 1867
7. G.L. Munion, J.F. Seaton, and T.S. Harrison HPLC for urinary catecholamines and metanephrines with alpha-methyldopa The Journal of Surgical Research 35 1983 507 514
8. L. Miano, R. Kolloch, and V. De Quattro Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites Clinica Chimica Acta 95 1979 211 217
9. H. Hallman, L.O. Farnebo, and B. Hamberger A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection Life Sciences 23 1978 1049 1052
10. G. Eisenhofer Analytical differences between the determination of plasma catecholamines by liquid chromatography with electrochemical detection and by radioenzymatic assay Journal of Chromatography 377 1986 328 333
11. P.M. Bouloux, and D. Perrett Interference of labetalol metabolites in the determination of plasma catecholamines by HPLC with electrochemical detection Clinica Chimica Acta 150 1985 111 117
12. F.D. Davidson Paracetamol-associated interference in an HPLC-ECD assay for urinary free metadrenalines and catecholamines Annals of Clinical Biochemistry 41 2004 316 320
13. P. Kumarathasan, and R. Vincent New approach to the simultaneous analysis of catecholamines and tyrosines in biological fluids Journal of Chromatography. A 987 2003 349 358
14. M.M. Kushnir, F.M. Urry, and E.L. Frank Analysis of catecholamines in urine by positive-ion electrospray tandem mass spectrometry Clinical Chemistry 48 2002 323 331
15. M.J. Whiting Simultaneous measurement of urinary metanephrines and catecholamines by liquid chromatography with tandem mass spectrometric detection Annals of Clinical Biochemistry 46 2009 129 136
16. W.H. de Jong, E.G. de Vries, and B.H. Wolffenbuttel Automated mass spectrometric analysis of urinary free catecholamines using on-line solid phase extraction Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences 878 2010 1506 1512
17. M. Peitzsch, D. Pelzel, and S. Glöckner Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites Clinica Chimica Acta 418 2013 50 58
18. T. Hasegawa, K. Wada, and E. Hiyama Pretreatment and one-shot separating analysis of whole catecholamine metabolites in plasma by using LC/MS Analytical and Bioanalytical Chemistry 385 2006 814 820
19. W. Li, D.T. Rossi, and S.T. Fountain Development and validation of a semi-automated method for L-dopa and dopamine in rat plasma using electrospray LC/MS/MS Journal of Pharmaceutical and Biomedical Analysis 24 2000 325 333
20. C. Ji, J. Walton, and Y. Su Simultaneous determination of plasma epinephrine and norepinephrine using an integrated strategy of a fully automated protein precipitation technique, reductive ethylation labeling and UPLC-MS/MS Analytical Chimica Acta 670 2010 84 91
21. M. Dunand, D. Gubian, and M. Stauffer High throughput and sensitive quantitation of plasma catecholamines by UPLC-tandem mass spectrometry using a solid phase microwell extraction plate Analytical Chemistry 2013 10.1021/ac4004584
22. K. Pacak, J.W. Lenders, and G. Eisenhofer Current trends in biochemical diagnosis of pheochromocytoma K. Pacak, J.W. Lenders, G. Eisenhofer, Pheochromocytoma: diagnosis, localization and treatment 1st ed. 2007 Blackwell Oxford 72 92
23. W.F. Young Pheochromocytoma: issues in diagnosis & treatment Comprehensive Therapy 23 1997 319 326
24. G. Eisenhofer, D.S. Goldstein, and M.M. Walther Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results Journal of Clinical Endocrinology and Metabolism 88 2003 2656 2666
25. T.C. Westfall, and D.P. Westfall Neurotransmission: the autonomic and somatic motor nervous system L.L. Brunton, B.A. Chabner, B.C. Knollmann, Goodman and Gilman's the pharmacological basis of therapeutics 12th ed. 2011 McGraw Hill Companies 171 218
26. C.M. Licht, E.J. de Geus, and A. Seldenrijk Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension Hypertension 53 2009 631 638
27. P.C. Waldmeier, K.H. Antonin, and J.J. Feldtrauer Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A European Journal of Clinical Pharmacology 25 1983 361 368
28. D. Hamaty, J.L. Valentine, and R. Howard The plasma endorphin, prostaglandin and catecholamine profile of patients with fibrositis treated with cyclobenzaprine and placebo: a 5-month study Journal of Rheumatology 19 1989 164 168
29. J.W. Lenders, K. Pacak, and M.M. Walther Biochemical diagnosis of pheochromocytoma: which test is best? The Journal of the American Medical Association 287 2002 1427 1434
30. T.C. Westfall, and D.P. Westfall Arenergic agonists and antagonists L.L. Brunton, B.A. Chabner, B.C. Knollmann, Goodman and Gilman's the pharmacological basis of therapeutics 12th ed. 2011 McGraw Hill Companies 277 334
31. L. Zendron, J. Fehrenbach, and C. Taverna Pitfalls in the diagnosis of phaeochromocytoma British Medical Journal 328 2004 629 630
32. R.R. Wenzel, G. Allegranza, and C. Binggeli Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics Journal of the American College of Cardiology 29 1997 1607 1614
33. A.J. Krentz, S. Mikhail, and P. Cantrell Drug points: pseudophaeochromocytoma syndrome associated with clozapine British Medical Journal 322 2001 1213
34. A.M. Sawka, R.J. Singh, and W.F. Young Jr. False-positive biochemical testing for pheochromocytoma caused by surreptitious catecholamine addition to urine The Endocrinologist 11 2001 421 423
35. H.J. Stuerenburg, K. Petersen, and T. Bäumer Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users Neuro Endocrinology Letters 23 2002 259 261
36. R.J. Devlin, and J.A. Henry Clinical review: major consequences of illicit drug consumption Critical Care 12 2008 202
37. J.F. Potter, L.T. Bannan, and J.B. Saunders Blood pressure and pressor mechanisms during alcohol withdrawal Journal of Hypertension 1 1983 97 99
38. M. Haass, and W. Kübler Nicotine and sympathetic neurotransmission Cardiovascular Drugs and Therapy 10 1997 657 665
39. W.H. de Jong, G. Eisenhofer, and W.J. Post Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors Journal of Clinical Endocrinology and Metabolism 94 2009 2841 2849
40. W.H. de Jong, W.J. Post, and M.N. Kerstens Elevated urinary free and deconjugated catecholamines after consumption of a catecholamine-rich diet Journal of Clinical Endocrinology and Metabolism 95 2010 2851 2855
41. D.S. Goldstein, G. Eisenhofer, and I.J. Kopin Sources and significance of plasma levels of catechols and their metabolites in humans The Journal of Pharmacology and Experimental Therapeutics 305 2003 800 811
42. P. Moleman Effect of diet on urinary excretion of unconjugated catecholamines and some of their metabolites in healthy control subjects and depressed patients Clinica Chimica Acta 189 1990 19 24
43. K. Pacak, J.W. Lenders, and G. Eisenhofer Clinical presentation of pheochromocytoma K. Pacak, J.W. Lenders, G. Eisenhofer, Pheochromocytoma: diagnosis, localization and treatment 1st ed. 2007 Blackwell Oxford 8 29
44. A. Pradalier, J.M. Launay, and J. Dry Common migraine. Changes in conjugated and unconjugated catecholamines Presse Medicale 14 1985 583 585
45. Y. Seçil, C. Unde, and Y.Y. Beckmann Blood pressure changes in migraine patients before, during and after migraine attacks Pain Practice 10 2010 222 227
46. T. Masuda, K. Sato, and S. Yamamoto Sympathetic nervous activity and myocardial damage immediately after subarachnoid hemorrhage in a unique animal model Stroke 33 2002 1671 1676
47. S. Douma, M. Doumas, and K. Petidis Intracerebral hemorrhage as the presenting feature of concurrent pheochromocytoma and paragangliomas Journal of Clinical of Hypertension (Greenwich) 10 2008 941 944
48. L.N. Graham, P.A. Smith, and J.B. Stoker Time course of sympathetic neural hyperactivity after uncomplicated acute myocardial infarction Circulation 106 2002 793 797
49. S. Subramanyam, and R.A. Kreisberg Pheochromocytoma: a cause of ST-segment elevation myocardial infarction, transient left ventricular dysfunction, and Takotsubo cardiomyopathy Endocrine Practice 18 2012 e77 80
50. B. Bandelow, G. Sengos, and D. Wedekind Urinary excretion of cortisol, norepinephrine, testosterone, and melatonin in panic disorder Pharmacopsychiatry 30 1997 113 117
51. O. Kuchel Pseudopheochromocytoma Hypertension 7 1985 151 158
52. Y. Sharabi, D.S. Goldstein, and O. Bentho Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma Hypertension 25 2007 2286 2295
53. F. Hakim, D. Gozal, and L. Kheirandish-Gozal Sympathetic and catecholaminergic alterations in sleep apnea with particular emphasis on children Frontiers in Neurology 3 2012 7
54. M.G. Ziegler, P.J. Mills, and J.S. Loredo Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea Chest 120 2001 887 893
55. G. Grassi, R. Dell'Oro, and F. Quarti-Trevano Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome Diabetologia 48 2005 1359 1365
56. E.J. Brunner, H. Hemingway, and B.R. Walker Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study Circulation 106 2002 2659 2665
57. Y. Kawano, T. Kawasaki, and N. Kawazoe Circadian variations of urinary dopamine, norepinephrine, epinephrine and sodium in normotensive and hypertensive subjects Nephron 55 1990 277 282
58. R.T. Peaston, T.W. Lennard, and L.C. Lai Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma Journal of Clinical Endocrinology and Metabolism 81 1996 1378 1384
59. G. Eisenhofer, F. Huysmans, and K. Pacak Plasma metanephrines in renal failure Kidney International 67 2005 668 677
60. K. Pacak, G. Eisenhofer, and H. Ahlman Pheochromocytoma: recommendations for clinical practice from the First International Symposium Nature Clinical Practice Endocrinology & Metabolism 3 2007 92 102
61. E. Grouzmann, L. Drouard-Troalen, and E. Baudin Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma European Journal of Endocrinology 162 2010 951 960
62. A.M. Sawka, R. Jaeschke, and R.J. Singh A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines Journal of Clinical Endocrinology and Metabolism 88 2003 553 558
63. E.L. Bravo, R.C. Tarazi, and F.M. Fouad Clonidine suppression test: a useful aid in the diagnosis of pheochromocytoma New England Journal of Medicine 305 1981 623 626
64. W.F. Young Endocrine hypertension S. Melmed, K.S. Polonsky, P.R. Larsen, Williams textbook of endocrinology 12th ed. 2011 Elsevier Philadelphia 545 580
65. D.R. McClean, L.M.T. Sinclair, and T.G. Yandle Malignant phaeochromocytoma with high circulating DOPA, and clonidine-suppressible noradrenaline Blood Pressure 4 1995 215 217
66. D.F. Davidson Phaeochromocytoma with normal urinary catecholamines: the potential value of urinary free metadrenalines Annals of Clinical Biochemistry 39 2002 557 566
67. R.T. Peaston, and C. Weinkove Measurement of catecholamines and their metabolites Annals of Clinical Biochemistry 41 2004 17 38
68. J.J. Willemsen, H.A. Ross, and J.W. Lenders Stability of urinary fractionated metanephrines and catecholamines during collection, shipment, and storage of samples Clinical Chemistry 53 2007 268 272
69. F. Boomsma, G. Alberts, and L. van Eijk Optimal collection and storage conditions for catecholamine measurements in human plasma and urine Clinical Chemistry 39 1993 2503 2508
70. N.B. Roberts, G. Higgins, and M. Sargazi A study on the stability of urinary free catecholamines and free methyl-derivatives at different pH, temperature and time of storage Clinical Chemistry and Laboratory Medicine 48 2010 81 87
71. E.C. Chan, P.Y. Wee, and P.C. Ho Evaluation of degradation of urinary catecholamines and metanephrines and deconjugation of their sulfoconjugates using stability-indicating reversed-phase ion-pair HPLC with electrochemical detection Journal Pharmaceutical and Biomedical Analysis 22 2000 515 526
72. G. Arnaldi, and M. Boscaro Adrenal incidentaloma Best Practice & Research Clinical Endocrinology & Metabolism 26 2012 405 419
73. E. Poirier, D. Thauvette, and J.C. Hogue Management of exclusively dopamine-secreting abdominal pheochromocytomas Journal of the American College of Surgeons 216 2013 340 346
74. G. Eisenhofer, G. Siegert, and J. Kotzerke Current progress and future challenges in the biochemical diagnosis and treatment of pheochromocytomas and paragangliomas Hormone and Metabolic Research 40 2008 329 337
75. R.T. Peaston, and S. Ball Biochemical detection of phaeochromocytoma: why are we continuing to ignore the evidence? Annals of Clinical Biochemistry 45 2008 6 10
76. E. Héron, G. Chatellier, and E. Billaud The urinary metanephrine-to-creatinine ratio for the diagnosis of pheochromocytoma Annals of Internal Medicine 125 1996 300 303
77. N.M. Kaplan, N.J. Kramer, and O.B. Holland Single-voided urine metanephrine assays in screening for pheochromocytoma Archives of Internal Medicine 137 1977 190 193
78. G. Eisenhofer, D.S. Goldstein, and P. Sullivan Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine Journal of Clinical Endocrinology and Metabolism 90 2005 2068 2075
79. L.A.G. Ries, M.A. Smith, and J.G. Gurney Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995 1999 National Cancer Institute Bethesda, MD NIH publication no. 99-4649
80. J.M. Maris, M.D. Hogarty, and R. Bagatell Neuroblastoma The Lancet 369 2007 2106 2112
81. N. Marchese, S. Canini, and L. Fabi Paediatric reference values for urinary catecholamine metabolites evaluated by high performance liquid chromatography and electrochemical detection European Journal of Clinical Chemistry and Clinical Biochemistry 35 1997 533 537
82. M. Tuchman, M.L. Ramnaraine, and W.G. Woods Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma Pediatrics 79 1987 203 205
83. V. Strenger, R. Kerbl, and H.J. Dornbusch Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients Pediatric Blood Cancer 48 2007 504 509
84. M. Monsaingeon, Y. Perel, and G. Simonnet Comparative values of catecholamines and metabolites for the diagnosis of neuroblastoma European Journal of Pediatrics 162 2003 397 402
85. M. Candito, E. Billaud, and M. Chauffert Biochemical diagnosis of pheochromocytoma and neuroblastomas Annales de Biologie Clinique 60 2002 15 36
86. A. Griffin, P. O'Shea, and R. FitzGerald Establishment of a paediatric age-related reference interval for the measurement of urinary total fractionated metanephrines Annals of Clinical Biochemistry 48 2011 41 44
87. E. Pussard, M. Neveux, and N. Guigueno Reference intervals for urinary catecholamines and metabolites from birth to adulthood Clinical Biochemistry 42 2009 536 539